Press release Biocartis Group NV: BIOCARTIS ANNOUNCES 2019 RESULTS AND 2020 OUTLOOK

NEXT STORY
Orion Corporation: Change in Orion Group Executive Management Board as of 1 April 2020
PREV STORY
Biocartis kondigt nieuw immuno-oncologie project aan met Bristol-Myers Squibb voor de registratie van de Idylla™ MSI test in China
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cidara Therapeutics to Present at Two Upcoming Conferences

SAN DIEGO, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology ...

author_avatar
NASDAQ Market News

Sorrento Announces Phase 2 Abivertinib Clinical Studies Have Completed Patient Enrollment in USA and Brazil with Top-Line Clinical Data Expected End of 3Q21

author_avatar
NASDAQ Market News

Crinetics Pharmaceuticals to Present at Leerink Partners Roundtable Series: Rare Disease & Oncology

SAN DIEGO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a ...

author_avatar
NASDAQ Market News